Entacapone Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global entacapone market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Entacapone is used by combining with levodopa/carbidopa for the treatment of the end-of-dose "wearing-off" effect in patients with Parkinson's disease. Parkinson's disease is a disorder of the central nervous. It is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. The major factor for the growth of the market is the increasing prevalence of Parkinson disease.
According to the Parkinson
Foundation, almost one million people are living with Parkinson disease in the
US which is expected to rise to 1.2 million in 2030. Additionally, approximately
60,000 Americans are diagnosed with PD each year and more than 10 million
people are living with PD globally. Further, PD disease increases with age
however, an estimated 4% of people with PD are diagnosed before age 50.
Moreover, the prevalence of PD in men are 1.5 times as compared to women.
However, increasing cost for the treatment of PD is hampering the growth of the
global entacapone market during the forecast period.
To Request a Sample of our Report on Entacapone Market: https://www.omrglobal.com/request-sample/entacapone-market
Some major key players in the market include Novartis
International AG, Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical
Industries Ltd., among others. The market players are contributing
significantly to the growth of the market by the adoption of various strategies
including mergers & acquisitions, geographical expansion, partnerships and
collaborations, and new product launches, to stay competitive in the market.
For instance, in February 2021, STADA declared European launch of the Lecigon
triple-combination of levodopa, carbidopa, and entacapone for treating advanced
Parkinson's disease.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
• Segment
Covered-
·
By Product
·
By Application
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape-Novartis
International AG, Teva Pharmaceutical Industries Ltd.,and Sun Pharmaceutical
Industries Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Entacapone Market is Available at: https://www.omrglobal.com/industry-reports/entacapone-market
Global Entacapone Market Report by Segment
By Product
• Purity:98%
• Purity:
above 98%
By Application
• Tablet
Product
• Capsule
Product
• Others
Global Entacapone Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment